Bharat Biotech Unveils Oral Cholera Vaccine Amid Global Shortage:
Bharat Biotech International Ltd has launched Hillchol (BBV131), a novel single-strain oral cholera vaccine (OCV) developed under license from Hilleman Laboratories. This launch is critical as global demand for OCVs exceeds 100 million doses annually, and there has been a deficit of approximately 40 million doses due to limited supply.